PATENT MEDICINE MARKET ANALYSIS (2020-2027) - PowerPoint PPT Presentation

About This Presentation



Read here the market research report on the “Patent Medicine Market" published by CMI Team – PowerPoint PPT presentation

Number of Views:97


Transcript and Presenter's Notes


  • Coherent Market Insights
  • Market Research and Business Consulting Services
  • https//
  • COVID-19 Impact Tracker

  • Patent Medicine Market - Global Industry
    Insights, Trends, Outlook, and Opportunity
    Analysis 2020 - 2027

  • A patent medicine, also known as Nostrum (our
    remedy), is a commercial product that is
    developed for the first time for a specific
    disease condition. It is initially sold under a
    brand name by which the physician can prescribe
    the drug for use of patients. Patent medicine is
    a concept, which means that only the
    pharmaceutical company that holds the patent is
    allowed to manufacture and make profit out of it.
    In most cases, drug patent is awarded for 20
    years to pharmaceutical companies. Moreover,
    sometimes the period of patent for drug has
    different lifespan in years according to its
    utility and in the country in which patent is
    been applied for approval. The effective period
    for patent drug is mostly seven to twelve years,
    as a company applies for patent prior to clinical
    trials to assess drug safety.

Global Patent Medicine Market Drivers
  • Patent medicine market is going to develop in
    coming over the forecast period, thus it will
    exhibit significant growth for pharmaceutical
    products due to increasing prevalence of diseases
    across the world. There are hundreds of medicine
    patent launches every year. For instance, in July
    2020, Pfizer Inc. submitted a patent application
    of tofacitinib oral sustained release form
    indicated for treatment of lupus, multiple
    sclerosis rheumatoid arthritis, and cancer.
    Furthermore, in July 2020, GlaxoSmithKline
    Biologicals SA patented dried saponin liposomal
    composition used in lyophilised form of
    immunogenic vaccine composition. Medicine patents
    are equally important for pharmaceutical
    companies. Patented products roughly generate
    half of revenue for pharmaceutical companies.

Global Patent Medicine Market - Impact of COVID-19
  • Sudden difficult situation of COVID-19 pandemic
    is affecting industries across the world.
    However, several industries are trying to
    overcome the financial situation. COVID-19 has
    affected the research and development in some
    fields of pharmaceutical industry, whereas
    surgical pharmaceutical industry is experiencing
    significant growth in patent filing due to rise
    in research and development in masks, infra-red
    thermometers, diagnostic kits, and mechanical

Global Patent Medicine Market Restraints
  • However, high cost of patent medicine as compared
    to generic medicine is expected to hamper growth
    of the patent medicine market. Generic medicine
    manufacturing companies incur less costs in
    developing generic medicines when compared to
    branded drug manufacturers. Moreover, majority of
    the pharmaceutical companies practise Patent
    Ever-greening, which means that they try to
    incur more revenue/profit by making minor changes
    in existing product using same base formula but
    different chemical structure formula and secure
    patent on it, thereby claiming it novel.
    Furthermore, patients in underdeveloped countries
    cannot afford patented medicines due to high
    cost. These factors are expected to restrain the
    global patent medicine market growth over the
    forecast period.

Global Patent Medicine Market - Regional Analysis.
  • On the basis of region, the global patent
    medicine market is segmented into North America,
    Latin America, Europe, Asia Pacific, Middle East,
    and Africa. The North America patent medicine
    system is effective and attracts investments from
    companies who want profit from pharmaceutical
    industry. Pharmaceutical companies in the U.S.
    are investing in research and development of
    novel medicines. For instance, in July 2020,
    Pfizer Inc patented its substituted
    carbonucleoside derivatives useful as anticancer
    agents. Key players in region are Pfizer Inc and
    Bristol-Myers Squibb.

  • Moreover, Europe has a growing market for
    pharmaceutical companies due to its increasing
    elderly population, above average expenditure on
    drugs, and robust use of branded drugs over
    generic equivalents. Therefore, the
    pharmaceutical companies in this region are
    focusing on research and development of novel
    medicines. For instance, in May 2020, Sanofi
    Pasteur Biologicals patented pharmaceutical
    composition containing toxins A and B, which
    increase stability of toxin in drug.
  • Furthermore, manufacturers in Asia Pacific region
    are increasing their focus on research and
    development in patent medicine market. For
    instance, in April 2020, Otsuka Pharmaceutical
    co., ltd, Japan, patented Cyanotriazole
    compounds, which improve hyperglycemia with less
    side effects and excellent safety and is useful
    in treating diabetes.

Global Patent Medicine Market - Competitive
  • Key players operating in the global patent
    medicine market include Pfizer Inc, Bristol-Myers
    Squibb, GlaxoSmithKline plc, Novartis
    International AG, Sanofi S.A, Merck Co., Inc.,
    Roche Holding AG, Amgen Inc, and AbbVie Inc.
  • Key Developments
  • In 2015, Pfizer Inc. (New York, NY) and Merck
    Sharp Dohme Corp. (Rahway, NJ) presented
    invention related to combination therapies useful
    for the treatment of cancer. In particular, the
    invention relates to a combination therapy, which
    comprises an antagonist of a Programmed Death 1
    protein (PD-1) and an inhibitor of anaplastic
    lymphoma kinase (ALK).

  • 2. In April 2020, Otsuka Pharmaceutical Co., Ltd.
    (Tokyo) patented invention related to an
    injectable preparation comprising
    y-1H-quinolin-2-one or a salt, which has a wide
    therapeutic spectrum for central nervous system
    diseases (particularly schizophrenia)
  • 3. In June 2020, GlaxoSmithKline Biologicals SA
    patented invention related to immunogenic
    compositions such as vaccines, comprising
    immunogenic polypeptides from Haemophilus
    influenzae and Moraxella catarrhalis, which is
    used for boosting immune response.

Global Patent Medicine Market Taxonomy
  • By Medicine Type
  • Solid Drug Products
  • Semi-solid Drug Products
  • Liquid Drug Products
  • Gas/aerosols Drug Products
  • Others
  • By Indication
  • Cardiovascular Disease
  • Respiratory Disease
  • Immunological Disease
  • Blood Disease
  • Gastrointestinal Disease
  • Ophthalmic Disease
  • Orthopedic Disease
  • Neurodegenerative Disease
  • Others

Global Patent Medicine Market Taxonomy
  • By Region
  • North America
  • Latent America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa

  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Buy Now
  • Referencehttps//

About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions.
  • What we provide
  • Customized Market Research Services
  • Industry Analysis Services
  • Business Consulting Services
  • Market Intelligence Services
  • Long term Engagement Model
  • Country Specific Analysis

Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt.Ltd.
  • Address 1001 4th Ave, 3200 Seattle, WA 98154,
  • Phone 1-206-701-6702
  • Email

  • Thank You!
  • Kindly follow CMI Social Media
    Profiles for the latest company updates
  • Facebook
  • Linkedin
  • Twitter
  • https//
Write a Comment
User Comments (0)